EXG001-307

· Guangzhou Jiayin Biotech Ltd

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for EXG001-307, covering 2024-08-28 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy [EARLY_Phase 1]

See pricing